Moneycontrol PRO
HomeNewsBusinessEarningsLincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y

Lincoln Pharma Consolidated March 2025 Net Sales at Rs 168.18 crore, up 18.03% Y-o-Y

June 24, 2025 / 13:02 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Reported Consolidated quarterly numbers for Lincoln Pharmaceuticals are:

    Net Sales at Rs 168.18 crore in March 2025 up 18.03% from Rs. 142.49 crore in March 2024.

    Quarterly Net Profit at Rs. 11.58 crore in March 2025 down 37.76% from Rs. 18.60 crore in March 2024.

    EBITDA stands at Rs. 19.84 crore in March 2025 down 21.92% from Rs. 25.41 crore in March 2024.

    Lincoln Pharma EPS has decreased to Rs. 5.78 in March 2025 from Rs. 9.28 in March 2024.

    Lincoln Pharma shares closed at 558.45 on June 20, 2025 (NSE) and has given -30.39% returns over the last 6 months and -9.28% over the last 12 months.

    Lincoln Pharmaceuticals
    Consolidated Quarterly Resultsin Rs. Cr.
    Mar'25Dec'24Mar'24
    Net Sales/Income from operations168.18146.55142.49
    Other Operating Income------
    Total Income From Operations168.18146.55142.49
    EXPENDITURE
    Consumption of Raw Materials53.9350.1651.89
    Purchase of Traded Goods14.7518.6117.00
    Increase/Decrease in Stocks11.48-0.134.69
    Power & Fuel------
    Employees Cost27.6227.9825.05
    Depreciation3.233.222.69
    Excise Duty------
    Admin. And Selling Expenses------
    R & D Expenses------
    Provisions And Contingencies------
    Exp. Capitalised------
    Other Expenses33.6926.2725.48
    P/L Before Other Inc., Int., Excpt. Items & Tax23.4920.4415.70
    Other Income-6.888.977.02
    P/L Before Int., Excpt. Items & Tax16.6129.4122.72
    Interest0.370.730.50
    P/L Before Exceptional Items & Tax16.2528.6822.22
    Exceptional Items------
    P/L Before Tax16.2528.6822.22
    Tax4.677.913.62
    P/L After Tax from Ordinary Activities11.5820.7718.60
    Prior Year Adjustments------
    Extra Ordinary Items------
    Net Profit/(Loss) For the Period11.5820.7718.60
    Minority Interest------
    Share Of P/L Of Associates------
    Net P/L After M.I & Associates11.5820.7718.60
    Equity Share Capital20.0320.0320.03
    Reserves Excluding Revaluation Reserves------
    Equity Dividend Rate (%)------
    EPS Before Extra Ordinary
    Basic EPS5.7810.379.28
    Diluted EPS5.7810.379.28
    EPS After Extra Ordinary
    Basic EPS5.7810.379.28
    Diluted EPS5.7810.379.28
    Public Share Holding
    No Of Shares (Crores)------
    Share Holding (%)------
    Promoters and Promoter Group Shareholding
    a) Pledged/Encumbered
    - Number of shares (Crores)------
    - Per. of shares (as a % of the total sh. of prom. and promoter group)------
    - Per. of shares (as a % of the total Share Cap. of the company)------
    b) Non-encumbered
    - Number of shares (Crores)------
    - Per. of shares (as a % of the total sh. of prom. and promoter group)------
    - Per. of shares (as a % of the total Share Cap. of the company)------
    Source : Dion Global Solutions Limited
    Broker Research
    first published: Jun 24, 2025 12:44 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347